US Stocks
/
CG Oncology, Inc. Share Price
CG Oncology, Inc. Share Price

CG Oncology, Inc. Share Price

NASDAQ: CGON | Mid Cap
$63.27
+$0.89 (1.43%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

CG Oncology, Inc. Stock Performance

Open
$61.93
Prev. Close
$62.38
Circuit Range
N/A
Day Range
$61.28 - $63.66
Year Range
$36.03 - $80.91
Volume
51,037
Average Traded
$62.74

CG Oncology, Inc. Share Price Today

As of 9 October 2026, CG Oncology, Inc.'s share price is $63.27. The stock opened at $61.93, compared to its previous close of $62.38. During today's trading session, CG Oncology, Inc.'s share price traded between $61.28 and $63.66, with an average price of $62.47. Over the past 52 weeks, the stock has recorded a high of $80.91 and a low of $36.03. In terms of performance, CG Oncology, Inc.'s share price has declined by 5.28% over the last six months and is up 46.05% on a year-on-year basis.

CG Oncology, Inc. Share Price Chart

$61.28$63.66
L
Show Current Price
H

CG Oncology, Inc. Stock Fundamentals & Key Indicators

Market Cap
$4.89B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.53
Revenue (TTM)
$4.04B
Return On Equity (TTM)
-21.80%
Profit Margin
-3985.15%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-80.46%

CG Oncology, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$1.67$2.32$1.08$1.16
Net Profit-$43.81-$41.31-$60.20-$79.06
Net Profit Margin-2623.35%-1780.60%-5574.07%-6815.52%
Income ChangeN/A5.71%-45.73%-31.33%

CG Oncology, Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$1.14$4.04
Net Profit-$88.04-$161.00
Net Profit Margin-7722.81%-3985.15%
Income ChangeN/A-82.87%

About CG Oncology, Inc.

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing its product candidate, cretostimogene grenadenorepvec, for patients with bladder cancer. The company's candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.

CG Oncology, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$70.67
$63.23
-10.92%
Sep 2026
$75.53
$70.99
-10.16%
Aug 2026
$71.04
$79.02
+11.02%
Jul 2026
$70.70
$71.17
+0.28%
Jun 2026
$61.27
$70.97
+14.01%
May 2026
$67.63
$62.26
-6.80%
Apr 2026
$68.22
$66.80
-1.46%
Mar 2026
$57.69
$67.79
+15.41%
Feb 2026
$51.97
$58.74
+12.99%
Jan 2026
$41.41
$51.98
+25.14%
Dec 2025
$45.11
$41.54
-7.25%
Nov 2025
$42.60
$44.78
+3.38%

CGON Share Price FAQs

What is CG Oncology, Inc. share price today?

chevron-up
CG Oncology, Inc. share price today is $63.27 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of CG Oncology, Inc. stock?

chevron-up
The 52 week high of CG Oncology, Inc. stock is $80.91, while the 52 week low is $36.03 as of 9 Oct '26.

What is CGON's market capitalisation today?

chevron-up
CGON market capitalisation is $4.89B as of October 9, 2026, at 7:15 am IST.

What is CGON's net income for the last quarter?

chevron-up
CGON's net income for the last quarter is -79.06B USD.

What is the 5 year returns of CGON?

chevron-up
The 5 year returns of CGON is 70.03% as on 9 Oct '26.

What is the high & low stock price of CGON today?

chevron-up
CGON stock price hit a high of $63.66 and low of $61.28 as of 9 Oct '26.

Can I buy CGON shares in India?

chevron-up
Yes. You can buy CGON in India by opening an international trading account.